A teen with Duchenne reports improvement on Solid’s gene therapy, and investors take notice – STAT
STAT |
A teen with Duchenne reports improvement on Solid's gene therapy, and investors take notice
STAT 14-year-old boy with Duchenne muscular dystrophy 1 has regained some strength and function in his muscles following treatment with an experimental gene therapy from Solid Biosciences, the boy's father tells STAT. And although it's just a single case … |
